Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Becker

Showing results (1521-1530 of 2,253) with videos related to

Pageof 226
Sort By:
Journal of Nephrology|January 11, 2002
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesisT D Hewitson, K J Kelynack, M G Tait, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 12, 2000
Cytotoxicity of combined essential fatty acids on a human prostate cancer cell lineE Motaung, S E Prinsloo, C H van Aswegen, et al.
Pediatric Nephrology (Berlin, Germany)|February 1, 1994
Triple immunosuppression with subsequent prednisolone withdrawal: 6 years' experience in paediatric renal allograft recipientsS M Chao, C L Jones, H R Powell, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Longitudinal impacts of habitat fragmentation on <i>Bartonella</i> and hemotropic <i>Mycoplasma</i> dynamics in vampire batsLauren R Lock, Kristin E Dyer, Dmitriy V Volokhov, et al.
Journal of Substance Abuse Treatment|December 27, 2011
Temporal relationship between substance use and delinquent behavior among young psychiatrically hospitalized adolescentsSara J Becker, Jessica E Nargiso, Jennifer C Wolff, et al.
Frontiers in Molecular Neuroscience|August 2, 2021
Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain OrganoidsHenrik Renner, Katharina J Becker, Theresa E Kagermeier, et al.
Journal of Substance Abuse Treatment|November 7, 2021
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19Robert Rosales, Tim Janssen, Julia Yermash, et al.
Stroke|December 7, 2002
Shortening the NIH Stroke scale for use in the prehospital settingDavid L Tirschwell, W T Longstreth, Kyra J Becker, et al.
American Journal of Clinical Oncology|November 10, 2021
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal CancerSalman R Punekar, Megan M Griffin, Lena Masri, et al.
Addiction Biology|September 30, 2011
Protracted abstinence from distinct drugs of abuse shows regulation of a common gene networkJulie Le Merrer, Katia Befort, Olivier Gardon, et al.
Pageof 226

Showing results (1521-1530 of 2,253) with videos related to

Sort By:
Pageof 226
Journal of Nephrology|January 11, 2002
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesisT D Hewitson, K J Kelynack, M G Tait, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 12, 2000
Cytotoxicity of combined essential fatty acids on a human prostate cancer cell lineE Motaung, S E Prinsloo, C H van Aswegen, et al.
Pediatric Nephrology (Berlin, Germany)|February 1, 1994
Triple immunosuppression with subsequent prednisolone withdrawal: 6 years' experience in paediatric renal allograft recipientsS M Chao, C L Jones, H R Powell, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Longitudinal impacts of habitat fragmentation on <i>Bartonella</i> and hemotropic <i>Mycoplasma</i> dynamics in vampire batsLauren R Lock, Kristin E Dyer, Dmitriy V Volokhov, et al.
Journal of Substance Abuse Treatment|December 27, 2011
Temporal relationship between substance use and delinquent behavior among young psychiatrically hospitalized adolescentsSara J Becker, Jessica E Nargiso, Jennifer C Wolff, et al.
Frontiers in Molecular Neuroscience|August 2, 2021
Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain OrganoidsHenrik Renner, Katharina J Becker, Theresa E Kagermeier, et al.
Journal of Substance Abuse Treatment|November 7, 2021
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19Robert Rosales, Tim Janssen, Julia Yermash, et al.
Stroke|December 7, 2002
Shortening the NIH Stroke scale for use in the prehospital settingDavid L Tirschwell, W T Longstreth, Kyra J Becker, et al.
American Journal of Clinical Oncology|November 10, 2021
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal CancerSalman R Punekar, Megan M Griffin, Lena Masri, et al.
Addiction Biology|September 30, 2011
Protracted abstinence from distinct drugs of abuse shows regulation of a common gene networkJulie Le Merrer, Katia Befort, Olivier Gardon, et al.
Pageof 226